Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 55,691 | 47,573 | 38,900 | 27,353 | 32,311 |
| Cost of Goods | 37,789 | 32,027 | 29,139 | 22,213 | 18,764 |
| Gross Profit | 17,902 | 15,546 | 9,761 | 5,140 | 13,547 |
| Operating Expenses | 101,183 | 88,748 | 101,152 | 92,437 | 88,931 |
| Operating Income | -82,492 | -73,175 | -91,252 | -87,084 | -74,620 |
| Interest Expense | 3,588 | 3,554 | 3,630 | 3,648 | 3,664 |
| Other Income | 8,505 | 6,896 | 6,867 | 6,348 | 1,313 |
| Pre-tax Income | -77,575 | -69,833 | -88,015 | -84,384 | -76,971 |
| Income Tax | -10,706 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -66,869 | -69,833 | -88,015 | -84,384 | -76,971 |
| Net Income | $-66,869 | $-69,833 | $-88,015 | $-84,384 | $-76,971 |
| EPS Basic Total Ops | -0.26 | -0.28 | -0.36 | -0.37 | -0.34 |
| EPS Basic Continuous Ops | -0.26 | -0.28 | -0.36 | -0.37 | -0.34 |
| EPS Diluted Total Ops | -0.26 | -0.28 | -0.36 | -0.37 | -0.34 |
| EPS Diluted Continuous Ops | -0.26 | -0.28 | -0.36 | -0.37 | -0.34 |
| EBITDA(a) | $-81,012 | $-72,269 | $-88,891 | $-83,853 | $-70,698 |